Target-MRD: A Game-Changer in Oncology Diagnostics January 22, 2025 HEALTH·Lite Blogs Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring blood test for solid organ Read More
